I guess if you compare the alternative prioducts being used under the same conditions, one could still expect better outcomes when using BTM
Disclaimer: I am not a medical professional and this is just a logical assumption
The Clinicians Speak, page-165
-
- There are more pages in this discussion • 838 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.27 |
Change
-0.140(5.81%) |
Mkt cap ! $1.566B | |||
| Open | High | Low | Value | Volume |
| $2.43 | $2.43 | $2.26 | $4.355M | 1.881M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 15056 | $2.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.28 | 50883 | 9 |
View Market Depth
| Last trade - 16.10pm 25/06/2024 (20 minute delay) ? |
| PNV (ASX) Chart |